Results 21 to 30 of about 13,217 (287)
Journal of the Korean Association of Oral and Maxillofacial Surgeons, 2023 Objectives Suspending bisphosphonates (BPs) to reduce the risk and severity of medication-related osteonecrosis of the jaw (MRONJ) remains controversial. In this study, we quantitatively evaluated the clinical significance of BP suspension before surgery
K. R. Mustakim +4 more
semanticscholar +1 more source
The Journal of Periodontology, 2022 BACKGROUND We investigated whether periodontal diseases contribute to the development of medication-related osteonecrosis of the jaw (MRONJ) in addition to tooth extraction, which is a major risk factor for MRONJ occurrence. METHODS This retrospective,
Min-Jeong Kwoen +6 more
semanticscholar +1 more source
Journal of the Korean Association of Oral and Maxillofacial Surgeons, 2023 Objectives Drug holidays are suggested to reduce the formation of osteonecrosis in patients under intravenous (IV) bisphosphonates (BPs) therapy. The objectives of this study are to evaluate the incidence of medication-related osteonecrosis of the jaw ...
Ç. Karaca +3 more
semanticscholar +1 more source
Neuralgia Inducing Cavitational Osteonecrosis of the Jaw: Scientific Controversy or pseudoscience? [PDF]
J Pain ResDavid A Keith Department of Oral and Maxillofacial Surgery, Harvard School of Dental Medicine, Visiting Oral and Maxillofacial Surgeon, Massachusetts General Hospital, Boston, MA, USACorrespondence: David A Keith, Department of Oral and Maxillofacial ...
Keith DA.
europepmc +2 more sources
Advances in Oral and Maxillofacial Surgery, 2023 Objective: The purpose of this study was to ascertain the correlation between COVID-19 infection and jaw osteonecrosis, along with the identification of risk factors that could be associated with the development of the condition. Another aim of our study
Mohd Aswad Khan +8 more
doaj +1 more source
Local delivery of hydrogel encapsulated vascular endothelial growth factor for the prevention of medication-related osteonecrosis of the jaw [PDF]
, 2021 The anti-angiogenic effects of bisphosphonates have been hypothesized as one of the major etiologic factors in the development of medication-related osteonecrosis of the jaw (MRONJ), a severe debilitating condition with limited treatment options.
Petcu, Eugen Bogdan +5 more
core +1 more source
Pathophysiology of Osteonecrosis of the Jaws [PDF]
Oral and Maxillofacial Surgery Clinics of North America, 2015 Osteonecrosis of the jaw (ONJ) is a multifactorial disease in patients with primary or metastatic bone malignancy or osteoporosis undergoing systemic antiresorptive therapy, where pathophysiology has not yet been fully determined. The staging of ONJ is based on severity of symptoms and extent of clinical and radiographic findings.
Aghaloo, Tara +2 more
openaire +4 more sources
HemaSphere, 2023 Book Citations: Authors, Title, HemaSphere, 2023;7(S3):pages. The individual abstract DOIs can be found at https://journals.lww.com/hemasphere/pages/default.aspx.
M. Gundesen +13 more
semanticscholar +1 more source
Medication-Related Osteonecrosis: Why the Jawbone?
Dentistry Journal, 2023 Medication-related osteonecrosis of the jaw (MRONJ) has emerged as a complication of anti-resorptive medications. Despite its low incidence rate, this problem has gained attention in recent years due to its devastating consequences and lack of preventive
Sydney Kuehn +2 more
doaj +1 more source
, 2020 In the past, osteonecrosis of the jaw (ONJ) was generally reported with bisphosphonate drugs; hence, the term BRONJ (bisphosphonate-related osteonecrosis of the jaw) was initially proposed.
Bakr, Mahmoud M +7 more
core +1 more source